Literature DB >> 11860664

Pneumomediastinum following Ecstasy (methylenedioxymetamphetamine, MDMA) ingestion in two people at the same 'rave'.

Darius Rejali1, Paul Glen, Nicholas Odom.   

Abstract

Ecstasy is a class A controlled drug often consumed by the young population for recreational purposes. Documented complications of its use include hyperpyrexia, disseminated intravascular coagulation (DIC), renal failure and rhabdomyolysis. We report on two patients who developed pneumomediastinum after Ecstasy abuse. Both patients obtained and consumed the drug at the same establishment and presented to the same hospital within half an hour. The possible pathogenesis of this complication are discussed and the literature reviewed. Pneumomediastinum should be recognized as a possible complication of Ecstasy use. Conservative management is appropriate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860664     DOI: 10.1258/0022215021910230

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  5 in total

1.  Bilateral pneumothorax, surgical emphysema and pneumomediastinum in a young male patient following MDMA intake.

Authors:  Nonyelum Evangeline Obiechina; Ahrane Jayakumar; Yusra Khan; James Bass
Journal:  BMJ Case Rep       Date:  2018-04-07

2.  [Unusual cause of pneumomediastinum].

Authors:  W Faber; A Hirner; M Kaminski
Journal:  Chirurg       Date:  2008-07       Impact factor: 0.955

Review 3.  Ecstasy-associated pneumomediastinum.

Authors:  Silvana F Marasco; H Kiat Lim
Journal:  Ann R Coll Surg Engl       Date:  2007-05       Impact factor: 1.891

4.  Extensive subcutaneous emphysema and pneumomediastinum after ecstasy ingestion.

Authors:  A Gungadeen; J Moor
Journal:  Case Rep Otolaryngol       Date:  2013-09-25

5.  A Case of Spontaneous Pneumomediastinum Following Ecstasy and Marijuana Use.

Authors:  Mishouri Paul; Prodip Paul; Dipon Dey; Amit Bhardwaj; Koushik Paul
Journal:  Cureus       Date:  2021-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.